You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,263,120


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,263,120 protect, and when does it expire?

Patent 8,263,120 protects AEMCOLO and is included in one NDA.

This patent has twenty-eight patent family members in twenty-one countries.

Summary for Patent: 8,263,120
Title:Oral antimicrobial pharmaceutical compositions
Abstract: The present invention relates to oral pharmaceutical compositions with controlled and/or programmed release containing at least one active ingredient having antimicrobial and/or anti-infectious activity for the treatment of infections of the large intestine, in particular the colon.
Inventor(s): Ajani; Mauro (Milan, IT), Bozzella; Roberta (Milan, IT), Celasco; Giuseppe (Genoa, IT), Villa; Roberto (Lecco, IT)
Assignee: Cosmo Technologies Ltd. (Dublin, IE)
Application Number:13/451,111
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,263,120: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 8,263,120, exploring its background, the patentability requirements it satisfies, and how it fits into the broader patent landscape.

Background of the Patent

United States Patent 8,263,120 was granted by the U.S. Patent and Trademark Office (USPTO), the federal agency responsible for reviewing patent applications and granting patents. The USPTO ensures that patents meet specific requirements outlined in U.S. patent law, particularly under the Patent Act[1].

Patentability Requirements

For a patent to be granted, it must satisfy several key requirements:

Eligible Subject Matter

The patent must be directed to a "process, machine, manufacture, or composition of matter, or any improvement thereof"[1]. This means the invention must fall within technological areas such as pharmaceuticals, biotechnology, computer hardware and software, etc. However, "laws of nature, natural phenomena, and abstract ideas" are not patentable as they are considered the "basic tools of scientific and technological work"[1].

Novelty Requirement

The claimed invention must be novel, meaning it was not patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention[1].

Nonobviousness Requirement

The invention must also be nonobvious, meaning it must be significantly different from existing knowledge (prior art) and not obvious to a person of ordinary skill in the relevant field[1].

The Alice/Mayo Test

For patents involving software or abstract ideas, the Supreme Court's Alice/Mayo test is applied. This two-step test first determines if the patent claims are "directed to" ineligible subject matter. If so, the second step assesses whether the patent claims have an "inventive concept" that transforms the nature of the claim into a patent-eligible application[1].

Patent 8,263,120: Specific Details

To analyze the scope and claims of Patent 8,263,120, one must review the patent document itself.

Title and Abstract

The title and abstract provide a high-level overview of the invention. This helps in understanding the core idea and the technological area it pertains to.

Claims

The claims section is the most critical part of the patent as it defines the scope of the invention. Each claim must be clear, concise, and definite, outlining what the inventor considers to be their invention[3].

Description and Drawings

The detailed description and drawings support the claims by explaining how the invention works and its various embodiments. This section helps in understanding the practical application and the inventive steps involved.

Analyzing the Claims

Claim Coverage Matrix

Using a Claim Coverage Matrix, as described by patent analytics services, one can categorize the claims by scope concepts. This helps in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Claim Charts

Interactive claim charts generated by tools like ClaimScape® can be used to review the patent coverage with technical experts. These charts help determine if the scope concepts of the patent claims are applicable to target products or methods, highlighting gaps in current coverage and future design opportunities[3].

Patent Landscape Analysis

Prior Art Search

Conducting a thorough prior art search using tools like the USPTO's Patent Public Search, Global Dossier, and other international patent databases is essential. This ensures that the invention is novel and nonobvious compared to existing knowledge[4].

Competitor Patents

Analyzing competitor patents in the same technological area helps in understanding the competitive landscape. This involves identifying overlapping claims, potential infringement risks, and opportunities for differentiation[3].

International Patent Considerations

Since patents are territorial, it is crucial to check if similar patents have been filed or granted in other countries. Databases like the European Patent Office's esp@cenet, Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE® can be used for this purpose[4].

Legal and Administrative Challenges

Inter Partes Review (IPR)

The Patent Trial and Appeal Board (PTAB) can hear challenges to the validity of patents through Inter Partes Review (IPR) proceedings. Petitioners can seek to invalidate a patent on grounds that it fails to meet patentability requirements[1].

Litigation

Patent disputes can also be resolved through litigation in federal courts. Understanding the legal framework and potential litigation risks is vital for maintaining and enforcing patent rights[5].

Key Takeaways

  • Patentability Requirements: Ensure the invention satisfies eligibility, novelty, and nonobviousness requirements.
  • Claims Analysis: Use tools like Claim Coverage Matrix and claim charts to understand the scope and coverage of the patent.
  • Patent Landscape: Conduct thorough prior art searches and analyze competitor patents to understand the competitive landscape.
  • International Considerations: Check for similar patents in other countries to ensure global protection.
  • Legal Challenges: Be prepared for potential IPR proceedings and litigation.

FAQs

Q: What is the primary role of the USPTO in patent law?

A: The USPTO is responsible for reviewing patent applications and granting patents, ensuring that inventions meet the requirements outlined in U.S. patent law[2].

Q: How does the Alice/Mayo test impact software patents?

A: The Alice/Mayo test determines if software patents are directed to ineligible subject matter and if they have an "inventive concept" that makes them patent-eligible[1].

Q: What is the purpose of a Claim Coverage Matrix in patent analytics?

A: A Claim Coverage Matrix helps categorize patents by claims and scope concepts, identifying which patents protect specific intellectual property and highlighting gaps or opportunities[3].

Q: How can one search for prior art related to a patent?

A: One can use the USPTO's Patent Public Search, Global Dossier, and other international patent databases to conduct a thorough prior art search[4].

Q: What is Inter Partes Review (IPR), and how does it affect patents?

A: IPR is a proceeding before the PTAB where petitioners can challenge the validity of a patent on grounds that it fails to meet patentability requirements[1].

Sources

  1. Congressional Research Service, "The Patent Trial and Appeal Board and Inter Partes Review," Updated May 28, 2024.
  2. USA.gov, "U.S. Patent and Trademark Office (USPTO)."
  3. Schwegman Lundberg & Woessner, "Patent Analytics."
  4. USPTO, "Search for patents."
  5. United States Courts, "Report on Filing Patent/Trademark."

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,263,120

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Redhill AEMCOLO rifamycin sodium TABLET, DELAYED RELEASE;ORAL 210910-001 Nov 16, 2018 DISCN Yes No 8,263,120 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,263,120

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
ItalyMI2004A1295Jun 25, 2004

International Family Members for US Patent 8,263,120

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1763339 ⤷  Subscribe 122019000048 Germany ⤷  Subscribe
European Patent Office 1763339 ⤷  Subscribe C201930053 Spain ⤷  Subscribe
European Patent Office 1763339 ⤷  Subscribe SPC/GB19/037 United Kingdom ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.